Skip to main content

Video

Pharmacy Learning Network
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Integrated Healthcare Executive
Matt Dickson, vice president of product and strategy and general manager of communication solutions at Stericycle, highlights the benefits of patient scheduling technology, explains how it has helped during the pandemic, and offers tips to health systems struggling to implement similar programs.
Pharmacy Learning Network
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and decision-making processes in pharmacy, and why it is…
Integrated Healthcare Executive
Matthew Michela, CEO, Life Image, explains why cloud adoption is essential for data sharing during the current pandemic and beyond, how organizations can prepare for ONC compliance deadlines, and provides advice for organizations who are looking to implement cloud-based technology in 2021.
Population Health Learning Network
Anthony Mato, MD, Memorial Sloan Kettering Cancer Center, discusses prognostic biomarker testing, treatment practices, and outcomes among patients with chronic lymphocytic leukemia (CLL) in the clinical practice setting, using the informCLL prospective registry.
Population Health Learning Network
Constantine Tam, MD, director of Hematology, St Vincent Hospital, discusses the phase 3 SYMPATICO study that examined the use ibrutinib plus venetoclax for the treatment of mantle cell lymphoma.
Population Health Learning Network
Based on a median follow-up of four years, John Allen, MD, assistant professor of Medicine in the Division of Hematology and Medical Oncology at Weill Cornell Medicine, New York-Presbyterian Hospital, explains how first-line ibrutinib-based treatment resulted in sustained efficacy with high…
Population Health Learning Network
William G. Wierda, MD, PhD, professor, Department of Leukemia, University of Texas MD Anderson Cancer Center, discusses the results of the Phase II CAPTIVATE study, and highlights how the use of Ibrutinib plus Venetoclax confers high rates of peripheral blood and bone marrow undetectable minimal…
Population Health Learning Network
Alfred L Garfall, MD, MS, assistant professor of Medicine, Perelman School of Medicine, University of Pennsylvania, discusses his recent study presented at ASH 2020, which examined the use of teclistamab for the treatment of multiple myeloma, highlighting a manageable safety profile, including low…
Population Health Learning Network
Deepu Madduri, MD, assistant professor, Hematology and Medical Oncology of the Mount Sinai Hospital, Mount Sinai Beth Israel, discusses the results of the CARTITUDE-1 study, which analyzed ciltacabtagene autoleucel, a CAR-T-cell therapy with 2 B-cell maturation antigen–targeting single-domain…
Back to Top